SCAD Genetics: Why Heart Attacks Hit Healthy Young Women

What They Found

Swedish researchers performed comprehensive genetic sequencing on 201 patients with spontaneous coronary artery dissection (SCAD) — a condition where the coronary artery wall spontaneously tears, causing heart attacks in otherwise healthy people. They found rare genetic variants in previously identified SCAD-associated genes and discovered novel genetic alterations that may explain why this condition disproportionately affects women without traditional cardiovascular risk factors.

Why It Matters

SCAD accounts for up to 35% of heart attacks in women under 50, yet the mechanism has remained largely mysterious. Unlike typical coronary artery disease driven by atherosclerotic plaque, SCAD involves structural weakness in the arterial wall itself — the media layer literally splits apart. This study advances our understanding of the genetic architecture underlying this arterial fragility.

The genetic findings have immediate clinical implications. Many SCAD patients present to emergency departments where physicians, seeing a young woman with chest pain and clean coronary arteries on initial imaging, may dismiss cardiac causes. Understanding the genetic predisposition helps validate that these patients have a real, heritable condition requiring specific management protocols.

From a longevity perspective, this research highlights how genetic variants affecting connective tissue integrity can create catastrophic cardiovascular events in seemingly low-risk individuals. The findings suggest SCAD may share genetic pathways with other connective tissue disorders like Ehlers-Danlos syndrome or Marfan syndrome, conditions already known to affect arterial wall structure.

What I'd Watch For

This is a preprint, so peer review hasn't validated the methodology or statistical approaches. The study size of 201 patients is reasonable for rare disease genetics, but replication in other populations will be critical before these findings influence clinical practice. I'd want to see functional studies showing how these genetic variants actually alter arterial wall mechanics.

The clinical relevance depends heavily on penetrance — what percentage of people carrying these variants actually develop SCAD? Without family studies or population controls, we can't determine if these are high-penetrance pathogenic variants or low-penetrance risk factors.

Bottom Line

This study moves SCAD from "mysterious condition" toward "understood genetic disorder," which is clinically valuable. However, genetic testing recommendations and family screening protocols should wait for peer review and replication studies. The findings won't immediately change acute management but may eventually guide risk stratification in relatives.